Article
Genetic variants in nucleotide excision repair pathway predict survival of esophageal squamous cell cancer patients receiving platinum-based chemotherapy.
Molecular carcinogenesis - 1 Nov 2018
Zhang Ruoxin, Zhou Fei, Cheng Lei, Yu Alexandria, Zhu Meiling, Wang Mengyun, Zhang Zhuanxu, Xiang Jiaqing, Wei Qingyi
Abstract excerpt
The benefits of platinum-based chemotherapy (PBC) on survival of esophageal squamous cell carcinoma (ESCC) patients are inexplicit due to the varied therapeutic effects. Nucleotide excision repair (NER) pathway plays a vital role in removing platinum-DNA adducts in tumor cells and hence may modulate the therapeutic effect and survival outcome. The present study assessed the associations of 26 potentially...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
